Point Out Caveats With Direct-to-Consumer Meds

January 2026

More drug companies and third-party platforms are selling Rx meds directly to patients...such as Eliquis, Wegovy, Xofluza, and Zepbound.

These direct-to-consumer (DTC) Rx programs appeal to patients by offering discounted and transparent pricing, convenience, privacy, etc.

But be aware that not all DTC programs translate into big savings...and there can be other caveats. Help weigh pros and cons.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote